Ifosfamide induced encephalopathy in a child with osteosarcoma.
Hakan SarbayÜlkü F DemirGüliz YılmazAbdullah A AtayBarış MalboraPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)
Patients who develop IIE can continue their treatment protocol with methylene blue prophylaxis and supportive therapy.